全文获取类型
收费全文 | 2458篇 |
免费 | 103篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 65篇 |
儿科学 | 180篇 |
妇产科学 | 81篇 |
基础医学 | 190篇 |
口腔科学 | 90篇 |
临床医学 | 178篇 |
内科学 | 569篇 |
皮肤病学 | 118篇 |
神经病学 | 230篇 |
特种医学 | 77篇 |
外科学 | 376篇 |
综合类 | 32篇 |
预防医学 | 71篇 |
眼科学 | 146篇 |
药学 | 90篇 |
中国医学 | 6篇 |
肿瘤学 | 84篇 |
出版年
2024年 | 2篇 |
2023年 | 20篇 |
2022年 | 40篇 |
2021年 | 50篇 |
2020年 | 44篇 |
2019年 | 47篇 |
2018年 | 66篇 |
2017年 | 45篇 |
2016年 | 63篇 |
2015年 | 78篇 |
2014年 | 102篇 |
2013年 | 138篇 |
2012年 | 204篇 |
2011年 | 186篇 |
2010年 | 139篇 |
2009年 | 91篇 |
2008年 | 136篇 |
2007年 | 214篇 |
2006年 | 198篇 |
2005年 | 185篇 |
2004年 | 129篇 |
2003年 | 118篇 |
2002年 | 93篇 |
2001年 | 25篇 |
2000年 | 15篇 |
1999年 | 23篇 |
1998年 | 11篇 |
1997年 | 10篇 |
1996年 | 16篇 |
1995年 | 5篇 |
1994年 | 9篇 |
1993年 | 2篇 |
1992年 | 5篇 |
1991年 | 9篇 |
1990年 | 7篇 |
1989年 | 5篇 |
1988年 | 7篇 |
1987年 | 2篇 |
1986年 | 5篇 |
1985年 | 4篇 |
1984年 | 3篇 |
1983年 | 2篇 |
1980年 | 3篇 |
1979年 | 2篇 |
1975年 | 2篇 |
1974年 | 4篇 |
1972年 | 2篇 |
1971年 | 2篇 |
1970年 | 5篇 |
1960年 | 2篇 |
排序方式: 共有2583条查询结果,搜索用时 109 毫秒
91.
Hepatic perfusion changes in an experimental model of acute pancreatitis: Evaluation by perfusion CT
Semra Tutcu Selim Serter Yavuz Kaya Eray Kara Nalan Ne?e Gökhan Pekindil Teoman Co?kun 《European journal of radiology》2010,75(2):203-206
Purpose
It is known that acute pancreatitis may cause secondary changes in several organs. Liver is one of these involved organs. In different experimental studies hepatic damages were shown histopathologically in acute pancreatitis but there are a few studies about perfusion disorders that accompany these histopathologic changes. Perfusion CT (pCT) provides the ability to detect regional and global alterations in organ blood flow. The purpose of the study was to describe hepatic perfusion changes in experimental acute pancreatitis model with pCT.Materials and methods
Forty Sprague-Dawley rats of both genders with average weights of 250 g were used. Rats were randomized into two groups. Twenty rats were in control group and 20 in acute pancreatitis group. pCT was performed. Perfusion maps were formed by processing the obtained images with perfusion CT software. Blood flow (BF) and blood volume (BV) values were obtained from these maps. All pancreatic and liver tissues were taken off with laparotomy and histopathologic investigation was performed. Student's t test was used for statistical analyses.Results
In pCT we found statistically significant increase in blood volume in both lobes of liver and in blood flow in right lobe of the liver (p < 0.01). Although blood flow in left lobe of the liver increased, it did not reach statistical significance.Conclusion
The quantitative analysis of liver parenchyma with pCT showed that acute pancreatitis causes a significant perfusion changes in the hepatic tissue. Systemic mediators seem to be effective as well as local inflammatory changes in perfusion changes. 相似文献92.
Baltacioğlu F Cimşit NC Cil B Cekirge S Ispir S 《Cardiovascular and interventional radiology》2003,26(5):434-439
Purpose: To report the results of
covered stent applications in iatrogenic vascular injuries.
Methods: We report 17 patients (11 men, 6 women; age range
20–59 years, mean age 40 years) who underwent repair of different
iatrogenic vascular lesions by means of endovascular covered stents.
The patient population consisted of 8 femoral arteriovenous fistulae, 4
common femoral artery pseudoaneurysms, 1 subclavian artery
pseudoaneurysm, 1 abdominal aortic aneurysm, 1 iliac artery
perforation, 2 porto-biliary fistulae that developed during TIPS
procedure. Balloon-expandable stent-grafts were used in all patients
except one. Control studies were performed with angiography.
Results: Technical success was achieved in all 17 patients.
The mean clinical follow-up period for all 17 patients was 8 months.
There were no signs of stent migration or leaks in the control studies.
Only one patient developed a hemodynamically insignificant stenosis at
the proximal end of the stent. There have been no stent deformations or
related complications during the follow-up period.
Conclusion: Our short-term results suggest that endovascular
treatment is a low-risk procedure and appears less invasive than
surgery for the treatment of different types of iatrogenic vascular
injuries. Intermediate and long-term results are not available. 相似文献
93.
Marcus R. Pereira Sumit Mohan David J. Cohen Syed A. Husain Geoffrey K. Dube Lloyd E. Ratner Selim Arcasoy Meghan M. Aversa Luke J. Benvenuto Darshana M. Dadhania Sandip Kapur Lorna M. Dove Robert S. Brown Russell E. Rosenblatt Benjamin Samstein Nir Uriel Maryjane A. Farr Michael Satlin Catherine B. Small Thomas J. Walsh Rosy P. Kodiyanplakkal Benjamin A. Miko Justin G. Aaron Demetra S. Tsapepas Jean C. Emond Elizabeth C. Verna 《American journal of transplantation》2020,20(7):1800-1808
Solid organ transplant recipients may be at a high risk for SARS‐CoV‐2 infection and poor associated outcomes. We herein report our initial experience with solid organ transplant recipients with SARS‐CoV‐2 infection at two centers during the first 3 weeks of the outbreak in New York City. Baseline characteristics, clinical presentation, antiviral and immunosuppressive management were compared between patients with mild/moderate and severe disease (defined as ICU admission, intubation or death). Ninety patients were analyzed with a median age of 57 years. Forty‐six were kidney recipients, 17 lung, 13 liver, 9 heart, and 5 dual‐organ transplants. The most common presenting symptoms were fever (70%), cough (59%), and dyspnea (43%). Twenty‐two (24%) had mild, 41 (46%) moderate, and 27 (30%) severe disease. Among the 68 hospitalized patients, 12% required non‐rebreather and 35% required intubation. 91% received hydroxychloroquine, 66% azithromycin, 3% remdesivir, 21% tocilizumab, and 24% bolus steroids. Sixteen patients died (18% overall, 24% of hospitalized, 52% of ICU) and 37 (54%) were discharged. In this initial cohort, transplant recipients with COVID‐19 appear to have more severe outcomes, although testing limitations likely led to undercounting of mild/asymptomatic cases. As this outbreak unfolds, COVID‐19 has the potential to severely impact solid organ transplant recipients. 相似文献
94.
Kuralay E Bolcal C Cingoz F Günay C Yildirim V Kilic S Ozal E Demirkilic U Arslan M Tatar H 《The Annals of thoracic surgery》2004,77(3):977-81; discussion 982
BACKGROUND: Division of the sternum is primarily a blind procedure in reoperation and carries an increased risk of injury for major cardiac structures in the presence of adhesions between the posterior table and the heart. METHODS: Two hundred patients were randomly divided into two groups. Cardiopulmonary bypass was established through the femoral artery and vein in group 1 (n = 100) patients before sternal reentry. Carpentier dual-stage femoral venous return cannula was used in all group 1 patients. Cardiopulmonary bypass was performed after sternal reentry in group 2 (n = 100) patients. RESULTS: Six severe cardiac injuries developed in group 2. Cardiopulmonary bypass time was 93 +/- 9 minutes in group 1 and 71 +/- 11 minutes in group 2 (p = 0.011), and the operation time was 155 +/- 23 minutes in group 1 and 185 +/- 32 minutes in group 2 (p = 0.024). Inotropic therapy was required in 52 patients in group 1 and 76 patients in group 2 (p = 0.032). Average chest drainage was 450 +/- 135 mL in group 1 and 850 +/- 250 mL in group 2 (p < 0.001). Average fresh whole blood transfusion was 3.3 +/- 1.2 U in group 1 and 5.8 +/- 0.9 U in group 2 (p = 0.033). Average intensive care unit stay was 2.2 +/- 1.3 days in group 1 and 4.5 +/- 2.3 days in group 2 (p = 0.025). Average hospital stay was 7.3 +/- 2.4 days in group 1 and 9.1 +/- 3.1 days for group 2 (p = 0.011). CONCLUSIONS: Cardiopulmonary bypass by bicaval Carpentier femoral venous cannula before resternotomy not only allows adequate cardiopulmonary bypass flow but also significantly reduces the risk of cardiac injury and catastrophic hemorrhage and allows safe reopening. Although this procedure increases cardiopulmonary bypass time, the operation time, bleeding, and blood transfusion requirement are significantly reduced. 相似文献
95.
96.
Serter S Gümüş B Unlü M Tunçyürek O Tarhan S Ayyildiz V Pabuscu Y 《Scandinavian journal of urology and nephrology》2006,40(3):212-214
OBJECTIVE: Testicular microlithiasis is a rare, usually asymptomatic, finding of the testes associated with various genetic anomalies and infertility. It is also widely believed that testicular microlithiasis is strongly associated with testicular tumor. The aim of this prospective study was to determine the true prevalence of testicular microlithiasis in an asymptomatic population by means of ultrasound screening. MATERIAL AND METHODS: Healthy male volunteers (17-42 years old) were recruited from the annual Army Reserve Officer Training Corps training camp at Manisa, Turkey. A screening genitourinary history was obtained and a physical examination and screening scrotal ultrasound scan were performed. RESULTS: All men diagnosed with testicular microlithiasis underwent complete clinical evaluations, physical examinations and determination of tumor markers. Fifty-three men with testicular microlithiasis were identified from the 2179 ultrasound scans, giving a prevalence of testicular microlithiasis of 2.4% in this asymptomatic population. The age (mean+/-SD) of subjects with testicular microlithiasis was 23.9+/-4.2 years (range 20-31 years). CONCLUSION: Our results suggest that there is no significant association between TM and testicular cancer, although it is difficult to rule out such an association without further studies with a longer follow-up period. 相似文献
97.
Selim S. Erbek MD 《Otolaryngology--head and neck surgery》2006,135(6):994; author reply 994-994; author reply 995
98.
Selcen Yuksel Selim Ayhan Vugar Nabiyev Montse Domingo-Sabat Alba Vila-Casademunt Ibrahim Obeid Francisco Sanchez Perez-Grueso Emre Acaroglu 《The spine journal》2019,19(1):71-78
BACKGROUND CONTEXT
Health-related quality of life (HRQOL) parameters have been shown to be reliable and valid in patients with adult spinal deformity (ASD). Minimum clinically important difference (MCID) has become increasingly important to clinicians in evaluating patients with a threshold of improvement that is clinically relevant.PURPOSE
To calculate MCID and minimum detectable change (MDC) values of total scores of the Core Outcome Measures Index (COMI), Oswestry Disability Index (ODI), Physical Component Summary (PCS), Mental Component Summary (MCS) of the Short Form 36 (SF-36), and Scoliosis Research Society 22R (SRS-22R) in surgically and nonsurgically treated ASD patients who have completed an anchor question at pretreatment and 1-year follow-up.STUDY DESIGN/SETTING
Prospective cohort.PATIENT SAMPLE
Surgical and nonsurgical patients from a multicenter ASD database.OUTCOME MEASURES
Self-reported HRQOL measures (COMI, ODI, SF-36, SRS-22R, and anchor question).METHODS
A total of 185 surgical and 86 nonsurgical patients from a multicenter ASD database who completed pretreatment and 1-year follow-up HRQOL scales and the anchor question at the first year follow-up were included. The anchor question was used to determine MCID for each HRQOL measure. MCIDs were calculated by an anchor-based method using latent class analysis (LCA) and MDCs by a distribution-based method.RESULTS
All differences between means of baseline and first year postoperative total score measures for all scales demonstrated statistically significant improvements in the overall population as well as the surgically treated patients but not in the nonsurgical group. The calculated MDC and MCID values of HRQOL parameters in the entire study population were 1.34 and 2.62 for COMI, 10.65 and 14.31 for ODI, 6.09 and 7.33 for SF-36 PCS, 6.14 and 4.37 for SF-36 MCS, and 0.42 and 0.71 for SRS-22R. The calculated MCID values for surgical and non-surgical treatment groups were 2.76 versus 1.20 for COMI, 14.96 versus 2.45 for ODI, 7.83 versus 2.15 for SF-36 PCS, 5.14 versus 2.03 for SF-36 MCS, and 0.94 versus 0.11 for SRS-22R; the MDC values for surgical and nonsurgical treatment groups were 1.22 versus 1.51 for COMI, 10.27 versus 9.45 for ODI, 5.16 versus 6.77 for SF-36 PCS, 6.05 versus 5.67 for SF-36 MCS, and 0.38 versus 0.43 for SRS-22R.CONCLUSIONS
This study has demonstrated that MCID calculations for the HRQOL scales in ASD using LCA yield values comparable to other studies that had used different methodologies. The most important finding was the significantly different MCIDs for COMI, ODI, SF-36 PCS and SRS-22 in the surgically and nonsurgically treated cohorts. This finding suggests that a universal MCID value, inherent to a specific HRQOL for an entire cohort of ASD may not exist. Use of different MCIDs for surgical and nonsurgical patients may be warranted. 相似文献99.
The global situation for people with mental illness – in developing and developed countries – is dire. Legislative and human
rights protections are frequently lacking. Mental health budgets are inadequate. There are insufficient numbers of skilled
policy makers, managers and clinicians. Communities are poorly informed about mental health and illness and not well organised
for purposes of advocacy. In most of the world, mental health services are inaccessible or of poor quality. Most people who
would benefit from psychiatric treatment and rehabilitation do not have affordable access to such services. Leadership – at
all levels – for mental health system development needs to be greatly strengthened. 相似文献
100.